• KN-62 Enables Precision Inhibition of CaMKII for Cell Signal

  2026-06-12

  KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, empowers researchers with targeted CaMKII inhibition, supporting robust workflows in calcium signaling, metabolism, and cell cycle studies. APExBIO’s formulation delivers reproducible results and unique selectivity, making it indispensable for dissecting complex cellular pathways.

• Omeprazole (A2845): Technical Guidance for Gastric Acid Stud

  2026-06-12

  Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor designed for research on gastric acid secretion and antiulcer mechanisms. It is best utilized in experimental workflows involving gastric acid-related disorders, but should not be used for clinical applications or long-term solution storage due to stability constraints.

• Cannabis Terpenes Relieve Neuropathic Pain via A2A Receptors

  2026-06-11

  Schwarz et al. elucidate that select terpenes from Cannabis sativa induce antinociceptive effects in mouse models of chronic neuropathic pain through activation of adenosine A2A receptors, rather than cannabinoid pathways. This mechanistic insight advances the understanding of non-cannabinoid components of Cannabis and supports the development of non-rewarding analgesic strategies for chronic pain.

• Baicalein: Applied Workflows for Cancer and Inflammation Res

  2026-06-11

  Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) stands out for its robust inhibition of the 12-lipoxygenase pathway, making it a preferred tool for dissecting cancer biology and inflammatory signaling. This guide translates recent mechanistic insights and experimental best practices into actionable protocols, troubleshooting advice, and advanced application scenarios for the modern research lab.

• Bismuth Subsalicylate in GI Research: Protocols and Troubles

  2026-06-10

  Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) stands out as a robust Prostaglandin G/H Synthase 1/2 inhibitor, enabling reproducible gastrointestinal disorder research. Explore advanced workflows, experimental enhancements, and targeted troubleshooting for high-impact GI and inflammation studies.

• Primidone (Mysoline): Deep Mechanistic Insights and Translat

  2026-06-10

  Explore how Primidone, an established antiepileptic drug, uniquely inhibits TRPM3 and RIPK1, advancing neurodegenerative and neurodevelopmental research. This article delivers a deeper mechanistic and translational analysis than standard guides.

• Arrb2 Drives M2 Macrophage Polarization to Mitigate Hepatic

  2026-06-09

  This study demonstrates that hepatocyte-expressed Arrb2 promotes M2 macrophage polarization via upregulation of the metabolite 6-ketoLCA, significantly reducing hepatic ischemia–reperfusion injury (IRI) in mouse models. The findings clarify the immunometabolic crosstalk underlying liver protection after IRI and highlight new avenues for therapeutic intervention in transplantation and hepatic surgery.

• Biomimetic Chromatography for Modeling Pulmonary Drug Permea

  2026-06-09

  This article examines a recent study that benchmarks biomimetic open tubular capillary electrochromatography and immobilised artificial membrane chromatography, both coupled with mass spectrometry, for predicting pulmonary drug permeability. The work advances high-throughput, physiologically relevant screening methods for respiratory drug development and highlights key methodological and interpretive insights.

• ORM2–ZG16 Axis Modulates Autophagy to Alleviate Pancreatic F

  2026-06-08

  This study reveals that ORM2, an acute-phase protein, mitigates pancreatic fibrosis in chronic pancreatitis by binding ZG16 to inhibit autophagy-driven activation of pancreatic stellate cells. The findings highlight a novel regulatory axis in pancreatic fibrosis and offer mechanistic insight for developing targeted antifibrotic strategies.

• Norovirus Hijacks NINJ1 for Selective Viral Protein Secretio

  2026-06-08

  Song et al. reveal that murine norovirus co-opts the host protein NINJ1 to selectively secrete its NS1 protein through a caspase-3–dependent, unconventional pathway. This discovery advances understanding of regulated cell death, selective DAMP release, and viral immune evasion strategies, with implications for apoptosis and chaperone inhibition research.

• Merimepodib (VX-497): IMPDH Inhibition and Host Metabolic Co

  2026-06-07

  Explore Merimepodib (VX-497) as a precise IMPDH inhibitor, dissecting its unique metabolic impact across antiviral, immunosuppressive, and cancer research. This article dives deeper than standard guides, revealing new insights into host metabolism and assay design.

• Ferrostatin-1 (Fer-1): Potent Ferroptosis Inhibition in Rese

  2026-06-06

  Ferrostatin-1 (Fer-1) is a selective ferroptosis inhibitor with nanomolar potency, widely used for studying iron-dependent oxidative cell death. Its precise mechanism involves suppressing lipid peroxidation and reactive oxygen species, making it essential in cancer biology and neurodegenerative disease models.

• (S)-(+)-Ibuprofen: Mechanistic Insight for Translational Imp

  2026-06-05

  Explore the mechanistic underpinnings and translational opportunities of (S)-(+)-Ibuprofen—a selective COX inhibitor central to inflammation pathway research. This article provides actionable guidance for researchers, integrates current evidence on efficacy, toxicity, and environmental impact, and positions APExBIO’s high-purity (S)-(+)-Ibuprofen as the standard for robust, responsible experimentation.

• Metoprolol: Selective Beta1-Adrenoceptor Antagonist in Resea

  2026-06-05

  Metoprolol’s precision as a selective beta1-adrenoceptor antagonist makes it indispensable for dissecting cardiovascular, inflammatory, and tumor biology mechanisms. This article delivers actionable protocols, troubleshooting insights, and comparative context—translating recent pharmacokinetic advances and APExBIO product reliability into workflow-ready strategies.

• Formononetin Blocks Oxaliplatin Neurotoxicity via Nrf2/HO-1

  2026-06-04

  This study demonstrates that formononetin protects sensory neurons from oxaliplatin-induced peripheral neurotoxicity by activating the Nrf2/HO-1 antioxidant pathway, while crucially preserving the chemotherapeutic’s anticancer efficacy. The findings address a major challenge in chemotherapy-induced neuropathy management and open pathways for safer adjunctive interventions.

507 records 12/34 page Previous Next First page 上5页 1112131415 下5页 Last page